Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

Concepts (384)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
44
2026
622
8.670
Why?
Chronic Pain
17
2024
183
5.510
Why?
Opioid-Related Disorders
17
2024
426
3.750
Why?
Drug Overdose
11
2024
170
3.620
Why?
Drug Prescriptions
16
2026
116
3.280
Why?
Medicaid
23
2021
294
2.510
Why?
Alcoholism
4
2022
242
2.240
Why?
Tramadol
3
2024
30
2.240
Why?
Antipsychotic Agents
10
2018
233
1.840
Why?
Retrospective Studies
47
2026
6821
1.820
Why?
Asthma
5
2025
319
1.820
Why?
Adult
60
2026
14541
1.680
Why?
Anticoagulants
7
2025
280
1.610
Why?
Humans
116
2026
53246
1.600
Why?
United States
54
2025
5413
1.580
Why?
Middle Aged
59
2025
13422
1.570
Why?
Pain
11
2022
353
1.390
Why?
Osteoarthritis, Knee
3
2017
97
1.390
Why?
Female
78
2026
28792
1.390
Why?
Adrenal Cortex Hormones
3
2025
116
1.380
Why?
Young Adult
30
2026
4514
1.360
Why?
Adolescent
39
2025
6912
1.330
Why?
Male
73
2025
27444
1.300
Why?
Health Care Costs
10
2022
178
1.270
Why?
Aged
46
2025
10430
1.270
Why?
Atrial Fibrillation
4
2016
196
1.170
Why?
Viscosupplements
3
2017
14
1.150
Why?
Venous Thromboembolism
3
2025
78
1.130
Why?
Hyaluronic Acid
3
2017
39
1.130
Why?
Mental Disorders
7
2025
446
1.100
Why?
Medication Adherence
6
2016
136
1.080
Why?
Emergency Service, Hospital
6
2016
530
1.060
Why?
Schizophrenia
5
2009
254
1.030
Why?
Hypoglycemic Agents
2
2025
227
1.030
Why?
Cross-Over Studies
2
2025
241
1.010
Why?
Cohort Studies
17
2024
1557
0.990
Why?
Arthroplasty, Replacement, Knee
4
2017
289
0.990
Why?
Analgesics, Non-Narcotic
3
2012
120
0.970
Why?
Acetaminophen
4
2015
277
0.950
Why?
Substance-Related Disorders
5
2021
630
0.940
Why?
Warfarin
4
2016
81
0.930
Why?
Patient Compliance
6
2009
232
0.910
Why?
Veterans
10
2024
580
0.890
Why?
Psychotropic Drugs
1
2025
79
0.840
Why?
Arkansas
15
2026
2068
0.840
Why?
Metformin
1
2025
84
0.830
Why?
Psychotherapy
1
2025
117
0.810
Why?
Suicide
1
2025
89
0.790
Why?
Prescription Drugs
6
2014
40
0.790
Why?
Cost-Benefit Analysis
5
2020
274
0.780
Why?
Risk Factors
16
2025
4018
0.760
Why?
Diabetes Mellitus, Type 2
2
2025
591
0.760
Why?
Insurance, Health
7
2020
146
0.740
Why?
Attention Deficit Disorder with Hyperactivity
1
2023
182
0.710
Why?
Neck Pain
2
2021
10
0.700
Why?
Central Nervous System Stimulants
1
2023
201
0.690
Why?
Back Pain
2
2021
40
0.690
Why?
Drug Utilization
11
2017
78
0.680
Why?
Hospitalization
6
2016
749
0.670
Why?
Arthralgia
1
2021
44
0.670
Why?
Professional-Patient Relations
1
2021
46
0.660
Why?
Stroke
3
2016
520
0.660
Why?
Insurance, Pharmaceutical Services
2
2019
25
0.650
Why?
Decision Support Techniques
3
2016
73
0.650
Why?
Databases, Factual
12
2026
742
0.630
Why?
Logistic Models
8
2016
947
0.620
Why?
Narcotic Antagonists
2
2024
150
0.610
Why?
Breast Neoplasms
4
2023
1223
0.590
Why?
Naloxone
1
2020
85
0.580
Why?
Hydrocodone
3
2024
20
0.580
Why?
Oxycodone
3
2024
27
0.580
Why?
Legislation, Drug
1
2019
18
0.570
Why?
Contraception
1
2019
31
0.560
Why?
Proton Pump Inhibitors
2
2016
95
0.560
Why?
Follow-Up Studies
8
2024
2318
0.530
Why?
Guidelines as Topic
1
2018
111
0.520
Why?
Mammography
1
2018
99
0.520
Why?
Practice Guidelines as Topic
3
2017
502
0.510
Why?
Buprenorphine
3
2024
162
0.510
Why?
Propensity Score
4
2025
170
0.500
Why?
Histamine H2 Antagonists
1
2016
28
0.500
Why?
Peptic Ulcer
1
2016
15
0.500
Why?
Purinergic P2Y Receptor Antagonists
3
2022
35
0.470
Why?
Time Factors
10
2025
2992
0.470
Why?
Pyridones
1
2016
38
0.470
Why?
Education, Pharmacy, Graduate
1
2016
21
0.470
Why?
Risk
4
2020
306
0.460
Why?
Aged, 80 and over
15
2025
3495
0.460
Why?
Safety-Based Drug Withdrawals
1
2015
7
0.460
Why?
Dextropropoxyphene
1
2015
6
0.460
Why?
Inappropriate Prescribing
1
2016
27
0.460
Why?
Insurance Claim Review
5
2010
42
0.450
Why?
Health Expenditures
3
2011
75
0.450
Why?
Tobacco Use Cessation
1
2015
10
0.450
Why?
For-Profit Insurance Plans
1
2015
2
0.450
Why?
Brain Ischemia
2
2016
162
0.440
Why?
Pyrazoles
1
2016
123
0.440
Why?
Mass Screening
1
2018
362
0.440
Why?
Quinolines
1
2015
44
0.430
Why?
Acetates
1
2015
51
0.430
Why?
Diabetic Neuropathies
1
2015
57
0.420
Why?
Anticonvulsants
2
2006
134
0.420
Why?
Stress, Psychological
1
2016
283
0.420
Why?
Opiate Substitution Treatment
3
2024
114
0.420
Why?
Insurance Claim Reporting
2
2011
11
0.420
Why?
Low Back Pain
2
2025
31
0.420
Why?
Critical Illness
1
2016
316
0.410
Why?
Controlled Substances
2
2024
7
0.410
Why?
Curriculum
2
2018
409
0.410
Why?
Palliative Care
1
2016
195
0.400
Why?
Pain Management
1
2015
185
0.400
Why?
Tobacco Products
1
2015
142
0.390
Why?
Neoplasms
1
2023
1335
0.380
Why?
Postoperative Complications
3
2025
1099
0.380
Why?
Injections, Intra-Articular
3
2017
38
0.380
Why?
Computers, Handheld
1
2013
23
0.380
Why?
Prescription Drug Misuse
3
2024
37
0.380
Why?
Evidence-Based Medicine
3
2014
275
0.370
Why?
United States Department of Veterans Affairs
5
2024
295
0.370
Why?
Neuralgia
2
2023
44
0.370
Why?
Medicare
7
2025
280
0.370
Why?
Carcinoma, Non-Small-Cell Lung
2
2025
175
0.360
Why?
Age Factors
6
2018
1136
0.360
Why?
Quality-Adjusted Life Years
3
2020
67
0.360
Why?
Benzodiazepines
3
2024
72
0.360
Why?
Cross-Sectional Studies
6
2022
1723
0.350
Why?
Child
11
2025
7384
0.340
Why?
Health Knowledge, Attitudes, Practice
1
2015
523
0.330
Why?
Case-Control Studies
7
2023
1212
0.330
Why?
Community Pharmacy Services
3
2020
71
0.320
Why?
Brain Neoplasms
2
2025
319
0.320
Why?
Health Personnel
1
2013
259
0.310
Why?
Kidney Failure, Chronic
2
2022
210
0.300
Why?
Employment
2
2015
94
0.300
Why?
Age Distribution
5
2018
175
0.290
Why?
Antidepressive Agents
2
2009
177
0.290
Why?
Motor Vehicles
1
2009
14
0.290
Why?
Automobile Driving
1
2009
27
0.290
Why?
Medication Errors
1
2009
24
0.290
Why?
Pharmacists
3
2019
155
0.280
Why?
Lung Neoplasms
2
2025
645
0.280
Why?
Hemorrhage
3
2023
226
0.280
Why?
Prevalence
5
2018
1034
0.270
Why?
Cost of Illness
3
2013
121
0.270
Why?
Physicians, Primary Care
2
2018
46
0.270
Why?
Pain Measurement
6
2021
259
0.270
Why?
Health Resources
2
2012
72
0.270
Why?
College Admission Test
2
2018
13
0.260
Why?
Antimanic Agents
1
2007
14
0.260
Why?
School Admission Criteria
2
2018
34
0.250
Why?
Schools, Pharmacy
2
2018
59
0.250
Why?
Markov Chains
2
2020
28
0.250
Why?
Pharmaceutical Services
2
2018
54
0.250
Why?
Georgia
6
2006
42
0.250
Why?
Orthopedic Procedures
2
2017
71
0.250
Why?
Constipation
1
2006
37
0.240
Why?
Overweight
1
2009
232
0.240
Why?
Multivariate Analysis
4
2017
598
0.240
Why?
Least-Squares Analysis
4
2011
44
0.240
Why?
Longitudinal Studies
3
2026
774
0.230
Why?
United States Food and Drug Administration
4
2011
93
0.230
Why?
Knee Joint
2
2017
166
0.230
Why?
Pancreaticoduodenectomy
1
2025
13
0.230
Why?
Platelet Aggregation Inhibitors
2
2021
213
0.230
Why?
Pancreatectomy
1
2025
19
0.230
Why?
Hepatectomy
1
2025
26
0.230
Why?
Odds Ratio
4
2020
567
0.230
Why?
Cranial Irradiation
1
2025
25
0.230
Why?
Students, Pharmacy
2
2018
134
0.220
Why?
Risperidone
2
2010
25
0.220
Why?
Colectomy
1
2025
36
0.220
Why?
North Carolina
5
2011
53
0.210
Why?
Polypharmacy
1
2004
16
0.210
Why?
Drug Costs
2
2020
40
0.210
Why?
Blood Glucose
2
2025
491
0.210
Why?
Pregnancy Outcome
1
2026
231
0.210
Why?
General Practitioners
1
2023
4
0.200
Why?
Severity of Illness Index
3
2017
1049
0.200
Why?
Patient Selection
1
2025
273
0.200
Why?
Haloperidol
1
2003
46
0.200
Why?
Renal Dialysis
2
2022
196
0.190
Why?
Pancreatic Neoplasms
1
2025
219
0.190
Why?
Motivation
1
2025
287
0.190
Why?
Direct Service Costs
1
2003
4
0.190
Why?
Dose-Response Relationship, Drug
5
2014
1367
0.190
Why?
Irritable Bowel Syndrome
1
2003
17
0.190
Why?
Aftercare
1
2023
73
0.190
Why?
Premedication
1
2002
17
0.180
Why?
Health Services Needs and Demand
1
2004
163
0.180
Why?
Common Cold
1
2002
5
0.180
Why?
Bronchitis
1
2002
10
0.180
Why?
Thromboembolism
1
2002
48
0.180
Why?
Proportional Hazards Models
4
2017
445
0.180
Why?
Advisory Committees
3
2018
75
0.180
Why?
Liver Neoplasms
1
2025
347
0.180
Why?
Accidents
1
2021
19
0.180
Why?
Respiratory Insufficiency
1
2023
119
0.170
Why?
Depressive Disorder, Major
2
2020
149
0.170
Why?
Forecasting
3
2009
152
0.170
Why?
Ambulatory Care Facilities
1
2002
121
0.170
Why?
Colorectal Neoplasms
1
2025
302
0.170
Why?
Pregnancy Complications
1
2026
406
0.170
Why?
Delivery of Health Care
2
2021
317
0.160
Why?
Respiratory Tract Infections
1
2002
82
0.160
Why?
Patient Discharge
1
2023
325
0.160
Why?
Mental Health Services
1
2004
233
0.160
Why?
Afghan Campaign 2001-
2
2018
39
0.160
Why?
Regression Analysis
5
2013
391
0.160
Why?
Interprofessional Relations
2
2018
95
0.160
Why?
Administration, Oral
2
2016
456
0.160
Why?
Obesity
1
2009
1205
0.160
Why?
Decision Making
5
2018
278
0.160
Why?
Administration, Intranasal
1
2020
30
0.160
Why?
Cardiovascular Diseases
2
2018
501
0.150
Why?
Economics, Pharmaceutical
2
2009
6
0.150
Why?
Treatment Outcome
8
2025
5597
0.150
Why?
Selection Bias
2
2009
15
0.150
Why?
Social Media
1
2022
125
0.150
Why?
Preventive Health Services
1
2020
53
0.150
Why?
Comparative Effectiveness Research
2
2009
50
0.150
Why?
Child, Preschool
5
2011
4164
0.140
Why?
Drug Administration Schedule
3
2011
370
0.140
Why?
Guideline Adherence
3
2025
143
0.140
Why?
Coronary Restenosis
1
2019
39
0.140
Why?
Sepsis
1
2021
240
0.140
Why?
Pregnancy
1
2026
2610
0.140
Why?
Insurance Coverage
1
2020
124
0.140
Why?
Health Care Surveys
2
2011
182
0.140
Why?
Infant, Newborn
1
2026
2913
0.140
Why?
Public Health Surveillance
1
2018
18
0.140
Why?
Thiazoles
2
2016
52
0.140
Why?
Sleep Deprivation
1
2018
18
0.140
Why?
Pharmacies
1
2019
62
0.140
Why?
Papillomavirus Vaccines
1
2019
74
0.130
Why?
Risk Assessment
3
2025
1368
0.130
Why?
Physicians
1
2021
242
0.130
Why?
Chronic Disease
5
2011
581
0.130
Why?
Metabolic Diseases
1
2018
47
0.130
Why?
Veterans Health
2
2014
61
0.130
Why?
Molecular Weight
1
2017
77
0.130
Why?
Acute Pain
1
2017
12
0.130
Why?
Coronary Vessels
1
2019
170
0.130
Why?
Papillomavirus Infections
1
2019
177
0.130
Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
Why?
Coronary Angiography
1
2019
369
0.130
Why?
Educational Measurement
1
2018
202
0.120
Why?
Eosinophils
1
2017
40
0.120
Why?
Monte Carlo Method
1
2016
89
0.120
Why?
Early Detection of Cancer
1
2018
190
0.120
Why?
Chilaiditi Syndrome
1
2015
1
0.120
Why?
Anti-Bacterial Agents
1
2002
832
0.110
Why?
Education, Pharmacy
1
2018
163
0.110
Why?
Incidental Findings
1
2015
43
0.110
Why?
Geriatrics
1
2016
42
0.110
Why?
India
1
2015
59
0.110
Why?
Health Services Accessibility
1
2020
477
0.110
Why?
Sex Distribution
1
2015
140
0.110
Why?
Thrombosis
1
2018
250
0.110
Why?
Models, Theoretical
1
2016
180
0.110
Why?
Sulfides
1
2015
29
0.110
Why?
Health Policy
3
2011
165
0.110
Why?
Cyclopropanes
1
2015
27
0.110
Why?
Pyridines
1
2016
135
0.110
Why?
Income
1
2015
106
0.110
Why?
Coronary Artery Disease
1
2019
324
0.110
Why?
Anti-Asthmatic Agents
1
2015
34
0.110
Why?
Renal Insufficiency, Chronic
1
2018
205
0.110
Why?
Societies, Medical
1
2016
207
0.110
Why?
Sarcopenia
1
2015
100
0.110
Why?
Self Report
1
2016
225
0.110
Why?
Educational Status
1
2015
229
0.100
Why?
Long-Term Care
3
2012
50
0.100
Why?
SEER Program
2
2025
106
0.100
Why?
Disease Progression
1
2017
880
0.100
Why?
Enoxaparin
2
2025
32
0.100
Why?
Comorbidity
5
2017
638
0.100
Why?
California
2
2004
93
0.100
Why?
Health Literacy
1
2015
132
0.100
Why?
Health Behavior
1
2015
261
0.100
Why?
Monitoring, Physiologic
1
2013
122
0.090
Why?
Prescriptions
2
2011
11
0.090
Why?
Sensitivity and Specificity
1
2015
869
0.090
Why?
Infant
3
2011
3808
0.090
Why?
Drug Therapy, Combination
2
2004
405
0.090
Why?
Managed Care Programs
1
2012
36
0.090
Why?
Predictive Value of Tests
2
2019
933
0.090
Why?
Ticlopidine
1
2012
71
0.090
Why?
Randomized Controlled Trials as Topic
2
2025
630
0.080
Why?
Deductibles and Coinsurance
1
2011
2
0.080
Why?
Hypertension, Pulmonary
1
2012
102
0.080
Why?
Incidence
3
2025
1085
0.080
Why?
Body Mass Index
2
2013
717
0.080
Why?
Calibration
1
2009
58
0.070
Why?
International Classification of Diseases
1
2009
70
0.070
Why?
Clozapine
2
2010
25
0.070
Why?
Analysis of Variance
1
2010
547
0.070
Why?
Reference Values
1
2009
311
0.070
Why?
Treatment Refusal
1
2009
35
0.070
Why?
Carbamazepine
1
2007
13
0.060
Why?
Lithium Compounds
1
2007
12
0.060
Why?
Mental Health
1
2010
249
0.060
Why?
Alendronate
1
2007
24
0.060
Why?
Fractures, Spontaneous
1
2007
15
0.060
Why?
Valproic Acid
1
2007
35
0.060
Why?
Internationality
3
2014
46
0.060
Why?
Chemotherapy, Adjuvant
1
2007
122
0.060
Why?
Osteoporosis, Postmenopausal
1
2007
29
0.060
Why?
Affect
1
2007
107
0.060
Why?
Drug Labeling
1
2006
11
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Data Collection
2
2009
288
0.060
Why?
Adrenergic beta-Agonists
1
2005
39
0.060
Why?
Self Disclosure
1
2005
12
0.060
Why?
Australia
1
2025
93
0.060
Why?
Multicenter Studies as Topic
1
2025
114
0.060
Why?
Drug Interactions
2
2018
196
0.050
Why?
Factor Analysis, Statistical
1
2004
90
0.050
Why?
Depression
1
2009
621
0.050
Why?
Eligibility Determination
1
2004
22
0.050
Why?
Urban Population
1
2005
162
0.050
Why?
Health Surveys
2
2018
248
0.050
Why?
Prescription Fees
1
2004
14
0.050
Why?
Length of Stay
1
2007
684
0.050
Why?
Algorithms
1
2007
668
0.050
Why?
Laparoscopy
1
2025
180
0.050
Why?
Data Interpretation, Statistical
3
2009
169
0.050
Why?
Prospective Studies
1
2008
2412
0.050
Why?
MEDLINE
1
2002
8
0.050
Why?
Cognition Disorders
1
2003
199
0.040
Why?
Antidepressive Agents, Second-Generation
1
2002
27
0.040
Why?
Analgesics
1
2023
104
0.040
Why?
Quality of Life
2
2023
902
0.040
Why?
Neuropsychological Tests
1
2003
345
0.040
Why?
Pharmacy
2
2018
55
0.040
Why?
Gastrointestinal Hemorrhage
1
2022
91
0.040
Why?
Patient Protection and Affordable Care Act
1
2020
62
0.040
Why?
Needs Assessment
1
2020
145
0.040
Why?
Ohio
1
2019
45
0.040
Why?
Myocardial Revascularization
1
2019
29
0.040
Why?
Quality of Health Care
1
2020
189
0.030
Why?
Pharmacoepidemiology
1
2017
7
0.030
Why?
Universities
1
2018
186
0.030
Why?
Research Design
2
2014
373
0.030
Why?
Vaccination
1
2019
310
0.030
Why?
Pilot Projects
1
2019
727
0.030
Why?
Communication
1
2018
263
0.030
Why?
Qualitative Research
1
2018
384
0.030
Why?
Electronic Health Records
1
2018
287
0.030
Why?
Attitude of Health Personnel
1
2018
371
0.030
Why?
Survival Analysis
1
2014
659
0.020
Why?
Ischemic Attack, Transient
1
2013
59
0.020
Why?
Lipids
1
2013
163
0.020
Why?
Linear Models
1
2013
287
0.020
Why?
Diagnosis, Dual (Psychiatry)
1
2012
42
0.020
Why?
Stress Disorders, Post-Traumatic
1
2017
411
0.020
Why?
Diagnostic Tests, Routine
1
2012
31
0.020
Why?
Cost Control
1
2011
13
0.020
Why?
Blood Pressure
1
2013
518
0.020
Why?
Acute Coronary Syndrome
1
2012
107
0.020
Why?
Reproducibility of Results
2
2005
1221
0.020
Why?
Dibenzothiazepines
1
2010
10
0.020
Why?
Adolescent Behavior
1
2011
112
0.020
Why?
Hypnotics and Sedatives
1
2010
74
0.020
Why?
Off-Label Use
1
2010
24
0.020
Why?
Observation
1
2009
8
0.020
Why?
Epidemiologic Methods
1
2009
47
0.020
Why?
Diabetes Mellitus
1
2013
321
0.020
Why?
Causality
1
2009
53
0.020
Why?
Mood Disorders
1
2009
60
0.020
Why?
Quinolones
1
2010
52
0.020
Why?
Anxiety Disorders
1
2009
133
0.020
Why?
Piperazines
1
2010
125
0.020
Why?
ROC Curve
1
2009
246
0.020
Why?
Headache
1
2008
75
0.020
Why?
Sex Factors
1
2009
747
0.020
Why?
Confidence Intervals
1
2007
158
0.020
Why?
Probability
1
2007
171
0.020
Why?
Drug Utilization Review
1
2005
22
0.010
Why?
Bone Density
1
2007
398
0.010
Why?
Drug Monitoring
1
2005
81
0.010
Why?
Registries
1
2007
652
0.010
Why?
Health Maintenance Organizations
1
2002
19
0.010
Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
Why?
Costs and Cost Analysis
1
2002
93
0.010
Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description